Elaine Duck

Risk Adjusting Survival Outcomes in Hospitals That Treat Patients With Cancer Without Information on Cancer Stage

David G. Pfister, David M. Rubin, Elena B. Elkin et al. · JAMA Oncology · 2015 · 142 citations · Full text

Medicine, Oncology, Cancer Control +16

Upfront plerixafor plus G-CSF versus cyclophosphamide plus G-CSF for stem cell mobilization in multiple myeloma: efficacy and cost analysis study

Salma Afifi, N. Adel, Sean M. Devlin et al. · Bone Marrow Transplantation · 2016 · 55 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Prospective Exploratory Analysis of the Association Between Tumor Response, Quality of Life, and Expenditures Among Patients Receiving Paclitaxel Monotherapy for Refractory Metastatic Breast Cancer

Shanu Modi, Katherine S. Panageas, Elaine Duck et al. · Journal of Clinical Oncology · 2002 · 29 citations

Medicine, Oncology, Pharmacoeconomics +17

Retrospective comparison of the effects of filgrastim and pegfilgrastim on the pace of engraftment in auto-SCT patients

Sherry Mathew, N. Adel, Robert D. Rice et al. · Bone Marrow Transplantation · 2010 · 21 citations

Pharmacy, Translational Sciences, Cell Therapy +7

Digitally Enabled Transitional Care Management in Oncology

Bobby Daly, Jennifer R. Cracchiolo, Jessie C. Holland et al. · JCO Oncology Practice · 2024 · 10 citations · Full text

Nursing, Health Informatics, Oncology +16